Evaluation and Management of Male Breast Mass
For a male patient presenting with a breast mass, begin with bilateral diagnostic mammography if age ≥25 years (or ultrasound if <25 years), followed by targeted ultrasound if mammography is indeterminate or suspicious, and proceed to image-guided core needle biopsy for any suspicious findings. 1
Initial Clinical Assessment
Perform a focused physical examination to distinguish gynecomastia from potential malignancy before ordering imaging. 2
Key clinical features to assess:
- Gynecomastia typically presents as a soft, rubbery, or firm mobile mass directly under the nipple, often painful (especially if present <6 months), and bilateral in ~50% of cases. 2
- Suspicious features requiring immediate imaging include: unilateral mass, hard or fixed consistency, eccentric location (not subareolar), nipple retraction, skin changes, bloody nipple discharge, or palpable lymphadenopathy. 1, 2, 3
- Most men with clear clinical gynecomastia or pseudogynecomastia (fatty tissue only) do not require imaging, as routine imaging leads to unnecessary benign biopsies. 2, 4
Age-Based Imaging Algorithm
Men ≥25 Years Old
Start with bilateral diagnostic mammography or digital breast tomosynthesis (DBT) as the initial imaging study. 1, 2, 5
- Mammography demonstrates 92-100% sensitivity, 90-96% specificity, and 99-100% negative predictive value for distinguishing benign from malignant disease in males. 1, 5
- Bilateral imaging is routinely performed to assess for symmetry and detect occult contralateral disease. 1
- If mammography is indeterminate or suspicious, proceed to targeted ultrasound to further characterize the lesion and guide biopsy. 1, 5
Men <25 Years Old
Begin with targeted ultrasound as the initial imaging modality, because breast cancer is extremely rare in this age group. 1, 2, 4
- If ultrasound shows suspicious or indeterminate features, proceed to mammography or DBT before making a biopsy recommendation. 2
- This approach prevents unnecessary biopsies, as gynecomastia and benign lesions can appear suspicious on ultrasound but are typically diagnosed as benign on mammography. 2
Biopsy Technique When Indicated
Image-guided core needle biopsy is the procedure of choice for suspicious breast masses, superior to fine-needle aspiration in sensitivity, specificity, and histological grading. 2, 5
Guidance method selection:
- Use ultrasound guidance when the lesion is visible on ultrasound (preferred due to real-time visualization, patient comfort, no radiation, and sampling accuracy). 2, 5
- Use stereotactic guidance for lesions visible only on mammography. 2
- Use DBT guidance for lesions visible only on tomosynthesis. 2
- Place a marker clip post-biopsy to document sampling location and perform post-biopsy imaging to confirm marker placement. 2, 5
Critical Considerations
Male breast cancer has a median age of 63 years and frequently presents at advanced stage with larger tumors and higher probability of nodal metastases. 1, 5
- The malignancy risk in men >60 years with pathologic nipple discharge reaches 32%. 6
- Approximately 50% of men with breast cancer may have coexisting gynecomastia, but gynecomastia itself is NOT a risk factor for breast cancer. 5
- Imaging should always precede biopsy, as post-biopsy changes may confuse image interpretation. 2
Common Pitfalls to Avoid
- Do not assume bilateral presentation excludes malignancy, especially in elderly males. 6
- Do not skip mammography in men ≥25 years, even if ultrasound appears benign, when clinical suspicion exists. 1
- Do not perform routine imaging for clear clinical gynecomastia without suspicious features, as this increases unnecessary biopsies without improving outcomes. 2, 4
- Do not rely on pain or lack thereof to distinguish gynecomastia from cancer—both can be asymptomatic or painful. 7